MATERIAL SAFETY DATA SHEET
This MSDS Complies With 29 CFR 1910.1200 (The Hazard Communication Standard)
This material safety data sheet conforms to the requirements of ANSI Z400.1
SECTION 1 ?CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
FR WG CONCEN ?FR WG Concentrate
Manufacturer/Supplier: Emergency Spill Information:
American Chemical Technologies, Inc.
485 E. Van Riper Road, Fowlerville, MI 48836 INFOTRAC 1-800-535-5053
Office: 517-223-0300 Fax: 517-223-1703 24 HOURS/DAY, 7 DAYS/WEEK
SECTION 2 ?COMPOSITION/INFORMATION ON INGREDIENTS
Component CAS# Range % by wt.
Purified Water 7732-18-5 <30%
2-(Diisopropylamino)ethanol 96-80-0 >4%
Morpholine 110-91-8 >3%
20 ppm TWA-OSHA (SKIN)
30 ppm STEL-OSHA
20 ppm TWA-ACGIH (SKIN)
Decanoic acid 334-48-5 >3%
Non-Hazardous Proprietary Proprietary >50%
SECTION 3 ?HAZARDS IDENTIFICATION
Emergency Overview: This product has been evaluated and does not require any hazard
warning on the label under OSHA criteria.
Potential Health Effects:
Eye Contact: No significant health hazard identified.
Skin Contact: Prolonged or repeated contact may cause skin irritation.
Inhalation: No significant health hazards identified.
Ingestion: Do not take internally. Harmful or fatal if swallowed.
HMIS Code: (Health:2) (Flammability:1) (Reactivity:0)
NFPA Code: (Health:2) (Flammability:1) (Reactivity:0)
Page 1 of 5
American Chemical Technologies, Inc. FR WG Concentrate
SECTION 4 ?FIRST AID MEASURES
Eye: Immediately irrigate with running water. If irritation develops get medical attention.
Skin: Thoroughly wash affected areas with soap and water. Remove and launder contaminated
clothing before reuse. If irritation develops, get medical attention.
Inhalation: Move to fresh air. Aid in breathing if necessary and get medical attention.
Ingestion: If swallowed, dilute with water and immediately induce vomiting. Never give fluids
or induce vomiting if the victim is unconscious or having convulsions. Get immediate medical
attention. Never give fluids or induce vomiting if the victim is unconscious or having
convulsions and get immediate medical attention.
Primary Routes of Entry: Breathing mists by inhalation or ingestion.
Effects of Acute Overexposure: Prolonged or repeated contact may result in skin or eye
irritation. Acute overexposure to morpholine vapors results in respiratory irritation and transient
eye irritation. Temporary foggy vision has been reported. Morpholine caused tearing of the
eyes, increased saliva, and tremors in rats and rabbits at lethal doses.
Chronic Overexposure Effects: At sub-lethal doses, morpholine caused tearing of eyes,
irritation and inactivity. Repeated skin applications with morpholine caused skin, liver, and
kidney injury in rabbits. Rats and guinea pigs exposed to 18,000-ppm morpholine exhibited eye
and respiratory irritation. Repeated exposures caused lung, liver, and kidney injury. In a 13-
week inhalation study with rats, morpholine caused nasal lesions at 100 and 250 ppm; no effects
were seen at 25 ppm. In an industry-sponsored study, morpholine was not carcinogenic to rats at
10, 50, or 100 ppm; but did cause ophthalmic and nasal lesions.
Aggravated Medical Conditions: No data is available that addresses medical conditions that
are generally recognized as being aggravated by exposure to this product. Please refer to Section
(effects of overexposure) for effects observed in animals.
SECTION 5 ?FIRE FIGHTING MEASURES
Flashpoint: >200 癋 Method: C.O.C. (after water has boiled away)
UEL: Not determined.
LEL: Not determined.
Autoignition Temperature: Not available
Flammability Classification: Not Flammable.
Extinguishing Media: Agents approved for Class B (e.g., dry chemical, carbon dioxide, foam,
steam) or water fog.
Unusual Fire and Explosion Hazards: There are no known unusual fire or explosion hazards.
Fire Fighting Equipment: Fire fighters should wear an approved self-contained breathing
apparatus. As with petroleum oils, maintain oil from spreading.
Page 2 of 5
American Chemical Technologies, Inc. FR WG Concentrate
Hazardous Combustion Products: Incomplete combustion results in oxides of sulfur and
carbon.
SECTION 6 ?ACCIDENTAL RELEASE MEASURES
General: Spills should be contained and placed in suitable containers for disposal in a licensed
facility. RCRA or CERCLA ("Superfund") does not regulate this material. Wear appropriate
respiratory protection and protective clothing and provide adequate ventilation during clean up.
Waste Disposal Method: Incinerate or bury in a licensed facility. DO NOT discharge into
waterways or sewer systems without proper authority. Dispose of in accordance with all
applicable local, state, and federal regulations.
SECTION 7 ?HANDLING AND STORAGE
Handling: No special requirements if handled with reasonable care.
Storage: Keep containers closed and protect from freezing.
SECTION 8 ?EXPOSURE CONTROLS/PERSONAL PROTECTION
Eye: Chemical splash goggles and a face shield if splashing hazard exists.
Skin: Gloves, coveralls, apron, and boots to prevent contact.
Inhalation: If vapors or mists are generated, wear a NIOSH/MSHA approved organic
vapor/mist respirator.
Engineering Controls: Control airborne concentrations below the exposure guidelines. Use
local exhaust to control vapors/mists.
Other Protective Equipment: Eyewash fountains and safety showers must be easily accessible.
Shower after handling.
SECTION 9 ?CHEMICAL AND PHYSICAL PROPERTIES
Appearance and Odor : Clear light brown viscous liquid with glycol odor
pH : 9.6
Vapor Pressure : 17 millibars @ 23 癈
Boiling Point : 221癋
Solubility in water : Complete
Specific Gravity : 1.073 (8.95 lb/gal)
Page 3 of 5
American Chemical Technologies, Inc. FR WG Concentrate
SECTION 10 ?STABILITY AND REACTIVITY
Stability: Stable.
Conditions to Avoid: No data available.
Materials to Avoid: No data available.
Hazardous Decomposition/Polymerization: No data available.
SECTION 11 ?TOXICOLOGICAL INFORMATION
Toxicological Information for morpholine
Oral: LD50 1.05 g/kg (rat) moderately toxic
Inhalation: believed to be practically non-toxic
Dermal:LD50 1.21 g/kg (rabbit) moderately toxic
Irritation Index, estimation of irritation (species)
Skin: (Draize) 8.0/8.0 (rabbit) corrosive
Eyes: (Draize) Believed to be >80-110/110 (rabbit) extremely irritating
Sensitization: although there has been secondary (anecdotal) reports of the potential for
morpholine to be a dermal sensitizer in humans, the weight of the available scientific
information indicates that morpholine is not expected to be a dermal sensitizer based on
animal and human skin patch testing data.
Prolonged and repeated exposure to morpholine vapors causes ocular, nasal, and skin
irritation in laboratory animals. Prolonged and repeated inhalation of morpholine vapors
did not cause cancer or organ damage in rats exposed for up to 2 years.
SECTION 12 ?ECOLOGICAL INFORMATION
Ecological testing has not been conducted on this product.
SECTION 13 ?DISPOSAL INFORMATION
Disposal must be in accordance with applicable federal, state, or local regulations.
SECTION 14 ?TRANSPORTATION INFORMATION
U.S. Dept. of Transportation
Shipping Name: not regulated
Hazard Class:
Identification number:
Page 4 of 5
American Chemical Technologies, Inc. FR WG Concentrate
SECTION 15 ?REGULATORY INFORMATION
TSCA Inventory Status Listed on Inventory: Yes
RCRA Hazard. Waste Number: N/A
This product is a physical hazard and a health hazard according to the OSHA Hazard
Communication Standard.
State regulatory Information: (by Component): NJ/PA/MA/RTK
CAS #: 96-80-0 No
Name: Ethanol, 2-(bis) 1-methyl
CAS #: 110-91-8 No
Name: Morpholine
CAS #: 334-48-5 No
Name: Decanoic Acid
CAS #: 7732-18-5 No
Name: Water
SECTION 16 ?SPECIAL PRECAUTIONS
This product does not contain or manufactured with Class I or Class II ozone-depleting
substances.
Prepared By: Mark D. Latunski
Date Revised: 4/20/2009
Supersedes: 11/29/2005
Date Prepared: 11/21/2002
The information provided herein is believed to be accurate to the best of the company's
knowledge as of the date of its issue. We do not warrant or guarantee the information provided
and will not be held liable for any loss or damage from its use.
Page 5 of 5
|